News

New non-coding genes that cause childhood neurodevelopmental disorders have been identified

An international consortium of scientists, with the participation of Spanish centres such as IDIBELL, CIBERER and the Germans Trias i Pujol University Hospital, has identified genetic variants in essential non-coding genes that cause previously undiagnosed neurodevelopmental disorders (NDDs) in patient cohorts. The findings have been published in the high-impact scientific journal Nature Genetics.   Beyond […]

Leer más about New non-coding genes that cause childhood neurodevelopmental disorders have been identified

“Active recipes” to prevent chronic diseases: the proposal of the +ACTIU project

In Catalonia we spend about 5 and a half hours a day in sedentary behaviour, without moving, which represents a clear risk factor for the development of chronic diseases. The numbers confirm this, given that 2 out of 5 adults have this type of disease. This situation is aggravated by the lack of available outdoor […]

Leer más about “Active recipes” to prevent chronic diseases: the proposal of the +ACTIU project

25 Genes linked to OCD discovered in largest genetic study ever on the disorder

The high-impact scientific journal Nature Genetics has published on Tuesday the study with the largest sample of patients affected by obsessive-compulsive disorder (OCD) ever analyzed

Leer más about 25 Genes linked to OCD discovered in largest genetic study ever on the disorder

Telemedicine reduces cardiovascular mortality in chronic heart failure by up to 54%

The combination of telemonitoring and teleintervention reduces episodes of decompensation by 70% and cardiovascular mortality by 54% in people with chronic heart failure.

Leer más about Telemedicine reduces cardiovascular mortality in chronic heart failure by up to 54%

Rediscovering denosumab: from osteoporosis treatment to a possible role against breast cancer

The first results of a clinical trial have emerged that reveal the potential for denosumab, an osteoporosis drug, to be used in breast cancer.

Leer más about Rediscovering denosumab: from osteoporosis treatment to a possible role against breast cancer

New oral drug shows high efficacy in HER2-mutated lung cancer

Zongertinib could become a new tool in the treatment of HER-2 mutated lung cancer, specially for an specific group of patients

Leer más about New oral drug shows high efficacy in HER2-mutated lung cancer
Scroll to Top